Dynamic Technology Lab Private LTD Erasca, Inc. Transaction History
Dynamic Technology Lab Private LTD
- $652 Million
- Q1 2025
A detailed history of Dynamic Technology Lab Private LTD transactions in Erasca, Inc. stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 10,389 shares of ERAS stock, worth $25,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,389Holding current value
$25,556% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ERAS
# of Institutions
152Shares Held
217MCall Options Held
258KPut Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA22.7MShares$55.9 Million1.52% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD20.3MShares$50 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY17.9MShares$43.9 Million4.49% of portfolio
-
Logos Global Management LP San Francisco, CA15MShares$36.9 Million2.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.5MShares$35.7 Million0.63% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $300M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...